Envestnet Asset Management’s Collegium Pharmaceutical COLL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$1.32M Buy
44,734
+13,842
+45% +$409K ﹤0.01% 3097
2025
Q1
$922K Buy
30,892
+6,554
+27% +$196K ﹤0.01% 3261
2024
Q4
$697K Buy
24,338
+152
+0.6% +$4.36K ﹤0.01% 3391
2024
Q3
$935K Buy
24,186
+3,692
+18% +$143K ﹤0.01% 3172
2024
Q2
$660K Buy
20,494
+3,465
+20% +$112K ﹤0.01% 3296
2024
Q1
$661K Sell
17,029
-2,951
-15% -$115K ﹤0.01% 3276
2023
Q4
$615K Buy
19,980
+2,020
+11% +$62.2K ﹤0.01% 3214
2023
Q3
$401K Buy
17,960
+2,119
+13% +$47.4K ﹤0.01% 3365
2023
Q2
$340K Sell
15,841
-1,218
-7% -$26.2K ﹤0.01% 3422
2023
Q1
$409K Sell
17,059
-614
-3% -$14.7K ﹤0.01% 3281
2022
Q4
$410K Sell
17,673
-28
-0.2% -$650 ﹤0.01% 3214
2022
Q3
$284K Buy
17,701
+1,599
+10% +$25.7K ﹤0.01% 3382
2022
Q2
$285K Buy
16,102
+74
+0.5% +$1.31K ﹤0.01% 3388
2022
Q1
$326K Buy
16,028
+3,058
+24% +$62.2K ﹤0.01% 3405
2021
Q4
$242K Sell
12,970
-4,340
-25% -$81K ﹤0.01% 3548
2021
Q3
$342K Buy
17,310
+2,631
+18% +$52K ﹤0.01% 3214
2021
Q2
$347K Buy
14,679
+621
+4% +$14.7K ﹤0.01% 3200
2021
Q1
$333K Sell
14,058
-258
-2% -$6.11K ﹤0.01% 3081
2020
Q4
$287K Buy
14,316
+3,289
+30% +$65.9K ﹤0.01% 2945
2020
Q3
$230K Buy
11,027
+173
+2% +$3.61K ﹤0.01% 2848
2020
Q2
$190K Buy
10,854
+630
+6% +$11K ﹤0.01% 2885
2020
Q1
$167K Buy
+10,224
New +$167K ﹤0.01% 2767
2017
Q2
Sell
-70
Closed -$1K 3057
2017
Q1
$1K Hold
70
﹤0.01% 3045
2016
Q4
$1K Buy
+70
New +$1K ﹤0.01% 3025